Outcomes in Patients With Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors

alexandrossfakianakis shared this article with you from Inoreader Outcomes in Patients With Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors via JAMA Otolaryngology–Head & Neck Surgery Current Issue This cohort study assesses survival outcomes and response rates among patients with recurrent or metastatic mucosal head and neck squamous cell carcinoma treated with checkpoint inhibitors with or without chemotherapy. View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.